Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
- PMID: 29340327
- PMCID: PMC5762962
- DOI: 10.1016/j.ekir.2017.09.005
Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
Abstract
Introduction: Melioidosis causes sepsis and death in the Top End of Northern Australia during the monsoonal wet season. Dialysis-dependent adults suffer higher melioidosis rates compared to low rates among renal transplant patients who routinely receive trimethoprim+sulfamethoxazole prophylaxis.
Methods: We performed a prospective interventional study to determine the efficacy and safety of daily trimethoprim+sulfamethoxazole prophylaxis in hemodialysis patients during the wet season, from 1 November 2014 to 30 April 2015. Hemodialysis (for ≥ 3 months) patients ≥ 18 years of age were offered treatment. A total of 269 patients on hemodialysis were eligible. Eight of the 269 patients (3%) were excluded from the analysis for being on melioidosis treatment. In all, 169 of 261 patients (64.8%) received the prophylaxis, and 92 of 261 patients (35.2%) did not, because of allergy history (n = 10), remoteness and logistical reasons (n = 60), poor dialysis attendance (n = 11), and refusal (n = 11). We monitored for clinical side effects 3 times weekly and neutropenia, thrombocytopenia, and liver function monthly throughout treatment and for 2 months posttreatment.
Results: In all, 169 of 261 patients (64.8%) received the prophylaxis. There was no age (years) difference by group (prophylaxis vs. nonprophylaxis, 54.7 [11.3] vs. 54.3 [11.2] [P = 0.751]). Sixteen of 261 patients (6%) had melioidosis. The event frequency was 0% (0/169, prophylaxis, vs. 17.4% [16/92, nonprophylaxis], P < 0.001). Higher thrombocytopenia and neutropenia rates were noted in the prophylaxis group. These did not warrant treatment stoppage. There was no difference in liver function. Three patients (1.8%) withdrew from the treatment because of side effects.
Conclusion: Daily dosing was effective and safe. Posthemodialysis dosing in the subsequent seasons was effective and safer. We recommend this approach in melioidosis-prevalent regions.
Keywords: hemodialysis; melioidosis; northern Australia; sepsis; trimethoprim+sulfamethoxazole; wet season.
Figures
References
-
- Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed
-
- Stephens D.P., Thomas J.H., Ward L.M. Melioidosis causing critical illness: a review of 24 years of experience from the Royal Darwin Hospital ICU. Crit Care Med. 2016;44:1500–1505. - PubMed
-
- Australian Bureau of Meteorology. Australian Bureau of Meteorology. (2017) Monthly Rainfall Climate Data, Darwin Airport. Australian Government [17 March 2017]. Available at: http://www.bom.gov.au/climate/data/. Accessed August 13, 2017.
-
- Limmathurotsakul D., Golding N., Dance D.A. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1 - PubMed
-
- Currie B.J., Kestli M. Epidemiology: a global picture of melioidosis. Nature. 2016;529:290–291. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous